Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo

References

• Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001; 194: 1625–38
   PubMed Web of Science ®Google Scholar
• Montserrat E, Bosch F, Rozman C. B-cell chronic lymphocytic leukemia: recent progress in biology, diagnosis, and therapy. Ann Oncol. 1997; 8(Suppl 1)93–101
   PubMed Web of Science ®Google Scholar
• Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Semin Oncol. 1998; 25: 27–33
   PubMed Web of Science ®Google Scholar
• Keating MJ. Chronic lymphocytic leukemia. Semin Oncol. 1999; 26: 107–14
   PubMed Web of Science ®Google Scholar
• Platsoucas CD, Fernandes G, Gupta SL, Kempin S, Clarkson B, Good RA, et al. Defective spontaneous and antibody dependent cytotoxicity mediated by E-rosette and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. J Immunol. 1980; 125: 1216–23
   PubMed Web of Science ®Google Scholar
• Semenzato G, Pezzuto A, Foa R, Lauria F, Raimondi R. T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptors. Clin Immunol Immunopathol. 1983; 26: 155–61
   PubMedGoogle Scholar
• Kunicka JE, Platsoucas CD. Defective helper function of purified T4 cells and excessive suppressor activity of purified T8 cells in patients with B-cell chronic lymphocytic leukemia. T4 suppressor effector cells are present in certain patients. Blood. 1988; 71: 1551–60
   PubMed Web of Science ®Google Scholar
• Briggs PG, Kraft N, Atkins RC. T cells and CD45R expression in B-chronic lymphocytic leukaemia. Leuk Res. 1990; 14: 155–9
   PubMed Web of Science ®Google Scholar
• Frolova EA, Richards SJ, Jones RA, Rawstron A, Master PS, Teasdale J, et al. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukemia (B-CLL). Leuk Lymphoma. 1995; 16: 307–18
   PubMed Web of Science ®Google Scholar
• Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, et al. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia. Blood. 1998; 91: 4273–81
   PubMed Web of Science ®Google Scholar
• Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40 ligand deficiency in chronic lymphocytic leukemia. Nat Med. 1987; 3: 984–9
   Google Scholar
• Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia. 1996; 10: 494–7
   PubMed Web of Science ®Google Scholar
• Dazzi F, D'Andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, et al. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol. 1995; 75: 26–32
   PubMedGoogle Scholar
• Prieto A, Garcia-Suarez J, Reyes E, Lapena P, Hemandez M, Alvares-Mon M. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Exp Hematol. 1993; 21: 1563–9
   PubMed Web of Science ®Google Scholar
• Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, et al. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol. 1994; 153: 4281–90
   PubMed Web of Science ®Google Scholar
• Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbation are preferentially seen within the CD4 T-cell subset. Blood. 1999; 94: 1063–9
   PubMed Web of Science ®Google Scholar
• Goolsby CL, Kuchnio M, Finn WG, Peterson L. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T cell population. Cytometry. 2000; 42: 188–95
   PubMedGoogle Scholar
• Rezvany MR, Jeddi-Tehrani M, Rabbani H, Lewin N, Avila-Carino J, Osterborg A, et al. Autologous T lymphocytes may specifically recognize leukemic B cells in patients with chronic lymphocytic leukemia. Br J Haematol. 2000; 111: 608–17
   PubMed Web of Science ®Google Scholar
• Krackhardt AM, Harig S, Witzens M, Broderick R, Barrett P, Gribben JG. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood. 2002; 100: 167–73
   PubMed Web of Science ®Google Scholar
• Husebekk A, Fellowes V, Read EJ, Williams J, Petrus MJ, Gress RE, et al. Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?. Cytotherapy. 2000; 2: 187–93
   PubMed Web of Science ®Google Scholar
• Shimoni A, Marcus H, Dekel B, Shkarchi R, Arditti F, Shvidel L, et al. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human/mouse radiation chimera. Cancer Res. 1999; 59: 5968–74
   PubMed Web of Science ®Google Scholar
• Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J, et al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics. 2006; 7: 59–74
   PubMed Web of Science ®Google Scholar
• Lottaz C, Yang X, Schied S, Spang R. OrderedList: a bioconductor package for detecting similarity in ordered gene list. Bioinformatics. 2006; 22: 2315–6
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics. 2007; 23: 700–7
   Web of Science ®Google Scholar
• Mi H, Guo N, Kejariwal A, Thomas PD. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res. 2007; 35: 247–52
   PubMed Web of Science ®Google Scholar
• Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen PK, Monteiro J, et al. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol. 1998; 161: 6674–80
   PubMedGoogle Scholar
• Gorski J, Piatek T, Yassai M, Gorski J, Maslanka K. Improvements in repertoire analysis by CDR3 size spectratyping. Bifamily PCR. Ann NY Acad Sci. 1995; 756: 99–102
   PubMed Web of Science ®Google Scholar
• Wu CJ, Chillemi A, Alyea EP, Orsini E, Neuberg D, Soiffer RJ, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood. 2000; 95: 352–9
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17: 2257–317
   PubMed Web of Science ®Google Scholar
• Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, et al. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia. J Immunol. 2005; 174: 2366–75
   PubMed Web of Science ®Google Scholar
• Vilà JM, Calvo J, Places L, Padilla O, Arman M, Gimferrer I, et al. Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. J Immunol. 2001; 166: 396–402
   PubMed Web of Science ®Google Scholar
• Di Ianni M, Terenzi A, Di Florio S, Falzetti F, Benedetti R, Iacucci R, et al. Activated autologous T lymphocytes exert an anti-tumoral effect against chronic lymphatic leukemia (CLL) cells. Blood. 2001; 98(Suppl 1)644
   Google Scholar
• Sheridan C. TeGenero fiasco prompts regulatory rethink. Nat Biotechnol. 2006; 24: 475–6
   PubMed Web of Science ®Google Scholar
• Knop S, Hebart H, Gratwohl A, Kliem C, Faul C, Holler E, et al. Treatment of steroid-resistant acute GvHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomised multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia. 2007; 21: 1830–3
   PubMed Web of Science ®Google Scholar
• Olive D, Chambost H, Sainty D, Stoppa AM, Blaise D, el Marsafy S, et al. Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2. Leukemia. 1994; 8: 1230–5
   PubMed Web of Science ®Google Scholar
• Rincón M, Dérijard B, Chow CW, Davis RJ, Flavell RA. Reprogramming the signaling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. Genes Funct. 1997; 1: 51–68
   PubMedGoogle Scholar
• Yang D, Conze D. A., Whitmarsh A, Barrett T, Davis R, Rincón M, et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity. 1998; 9: 575–85
   PubMed Web of Science ®Google Scholar
• Rossmann ED, Lewin N, Jeddi-Tehrani M, Österborg A, Mellstedt H. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol. 2002; 68: 299–306
   PubMed Web of Science ®Google Scholar
• Gorgun G, Holderried TAW, Zahrieh D, Neuberg D, Gribben JG. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest. 2005; 115: 1797–805
   PubMed Web of Science ®Google Scholar
• Arditti FD, Aviner S, Dekel B, Krauthgamer R, Gan J, Nagler A, et al. Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs. Blood. 2005; 105: 3365–71
   PubMed Web of Science ®Google Scholar